SPS 2015: The CiPA initiative – How it will change the way we do drug development in the future
The CiPA initiative – How it will change the way we do drug development in the future. Symposia at the 2015 Annual Meeting of the Safety Pharmacology Society (SPS) Praque, Czech Republic, Sept 29, 2015.
See the video presentations below:
By Bernard Fermini. Ph.D.
- CiPA Steering commitee board member
- Chairman CiPA Ion Channel Working Group
- Ion Channel Discipline Lead Global Safety Pharmacology at Pfizer Groton, Connecticut, USA
Title: CiPA – The four letter word that may revolutionize in vitro cardiac safety testing.
By Simon Hebeisen. Ph.D. – Chief Scientific Officer B’SYS, Witterswil, Switzerland
Title: Evolving Market Needs in Safety screening: beyond hERG and CiPA
By Marc Rogers, Phd – Metrion Biosciences
Title: Using high quality HTS automated patch clamp data from human cardiac ion channels and in silico action potential modelling to cost–effectively predict QT prolongation and arrhythmia risk for CiPA